ASSET PURCHASE AGREEMENTAsset Purchase Agreement • July 8th, 2009 • Interleukin Genetics Inc • In vitro & in vivo diagnostic substances • Delaware
This Asset Purchase Agreement (this “Agreement”) is entered into on July 1, 2009 by and among AJG Brands, Inc., a Delaware corporation (“Alan James Group”) and Interleukin Genetics, Inc., a Delaware corporation and the sole shareholder of Alan James Group (the “Shareholder”) (Alan James Group is sometimes referred to as the “Company,” and, collectively with the Shareholder, the “Sellers”), Pep Products, Inc., a Delaware corporation (the “Buyer”) and Nutraceutical Corporation, a Delaware corporation and the sole shareholder of the Buyer (the “Buyer Parent”).
